30 DIRECTORS’ REPORT Details of remuneration Amounts of remuneration Details of the remuneration of key management personnel of the consolidated entity are set out in the following tables. The KMP of the consolidated entity consisted of the following directors of Kazia Therapeutics Limited: • Iain Ross - Non-Executive Director, Chairman • Bryce Carmine - Non-Executive Director • Steven Coffey - Non-Executive Director • Dr James Garner - Managing Director, CEO And the following persons: • Kate Hill - Company Secretary • John Friend - Chief Medical Officer - from 15 November 2021 • Gabrielle Heaton - Director Finance & Administration - to 2 January 2022 • Karen Krumeich - Chief Financial Officer - from 3 January 2022 Changes within the reporting period: John Friend was appointed as Chief Medical Officer and commenced employment on 15 November 2021. Karen Krumeich was appointed as Chief Financial Officer and commenced employment on 3 January 2022. Consequently Gabrielle Heaton is no longer considered to be key management personnel and therefore only remuneration from 1 July 2021 to 2 January 2022 is shown below. Short-term benefits Postemployment benefits Sharebased payments Movements in accrued leave Non- monetary Movements in long service leave Nonmonetary Healthcare & Insurance Cash Salary & fees Cash Bonus Cash Super- annuation Options Equity- settled Total 2022 $ $ $ $ $ $ $ $ Non-Executive Directors: I Ross* 150,546 - - - - - 46,159 196,705 B Carmine 85,000 - - - - 8,500 46,159 139,659 S Coffey 85,000 - - - - 8,500 46,159 139,659 Executive Directors: J Garner 530,500 325,000 35,905 12,074 - 85,550 1,015,198 2,004,227 Other Key Management Personnel: J Friend** 430,279 201,978 34,336 - 26,819 - 250,194 943,606 K Krumeich*** 277,972 - 15,272 - 6,307 - 100,331 399,882 G Heaton 104,000 30,000 2,337 19,262 - 13,400 27,910 196,909 K Hill 195,501 21,000 - - - - 27,820 244,321 1,858,798 577,978 87,850 31,336 33,126 115,950 1,559,930 4,264,968 * Salary paid in UK pounds, but disclosed in Australian dollars using conversion rate of 0.5447 ** Salary paid in USD, but disclosed in Australian dollars using conversion rate of 0.7192 *** Salary paid in USD, but disclosed in Australian dollars using conversion rate of 0.7195
RkJQdWJsaXNoZXIy MjE2NDg3